Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours: A Comparative Effectiveness and Safety Study [Clinical Sciences]

Conclusions—
The low-dose alteplase strategy was comparable to the standard-dose treatment in terms of the effectiveness and safety.

Source: Stroke - August 24, 2015 Category: Neurology Authors: Kim, B. J., Han, M.-K., Park, T. H., Park, S.-S., Lee, K. B., Lee, B.-C., Yu, K.-H., Oh, M. S., Cha, J. K., Kim, D.-H., Lee, J., Lee, S. J., Ko, Y., Park, J.-M., Kang, K., Cho, Y.-J., Hong, K.-S., Kim, J.-T., Choi, J. C., Kim, D.-E., Shin, D.-I., Kim, W.- Tags: Thrombolysis Clinical Sciences Source Type: research